Dr. Rolfo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Tisch Cancer Institute, Center for Thoracic Oncology, Mount Sinai
1176 Fifth Ave
New York, NY 10029Phone+1 212-827-7227
Summary
- SHARE: Open Share Modal Print
Christian Rolfo, MD, PhD, MBA
Professor of Medicine
#
Specialties:
Medical Oncology
About Education
Toggle accordion item
Christian Rolfo, MD, PhD, MBA is the director of the Thoracic Medical Oncology and the Early Clinical Trials at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). He specializes in thoracic oncology, drug development and translational oncology.
Dr. Rolfo is also a professor in the Division of Hematology-Oncology at University of Maryland School of Medicine.
Dr. Rolfo received his medical degree from the National University of Córdoba, Argentina in 1996. He completed his residency at University of Milan, Italy. He has earned certifications from the European Oncology Board and the Spanish and Belgian Board and spent an internship at MD Anderson Cancer Center in Houston.
From 2012 to March 2018, Dr. Rolfo was senior staff for the Thoracic Oncology Cluster at the Antwerp University Hospital in Belgium. There he directed the Phase I ─ Early Clinical Trials Unit and the Clinical Trials Management Program.
Dr. Rolfo actively works on drug development and resistance in lung cancer and mesothelioma treatment. His focus of research are liquid biopsies (exosomes and ctDNA) and molecular profling, he is involved in druggable biomarkers research and immunotherapy in thoracic cancer.
Dr. Rolfo is on the educational Committee of the International Association for the Study of Lung Cancer (IASLC), Membership Committee of European Society of Medical Oncology (ESMO) and Educational Chair of the International Society of Liquid Biopsies(ISLB). He is a member of the American Society of Clinical Oncology (ASCO) and other societies.
His work has been published in “New England Journal of Medicine,” “Lancet Oncology,” “Nature Nanotechnology,” “Lung Cancer” and other journals. Speaking engagements include global forums on lung cancer and drug develop
Education & Training
- MD Anderson Cancer CenterInternship, 2013 - 2013
- Polytechnic University of Valencia, SpainMBA, Health, 2008 - 2009
- University of Palermo, ItalyPhD, Experimental Oncology, Cum Laude, 2006 - 2009
- University of Milan, ItalyFellowship, 2000 - 2003
- Universidad Nacional de CordobaClass of 1996
Certifications & Licensure
- NY State Medical License 2020 - 2026
- MD State Medical License 2018 - 2021
Awards, Honors, & Recognition
- Jean Dausset Award Royal College of Medicine, Balearic Islands, Spain, 2009
Clinical Trials
- M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC) Start of enrollment: 2019 Apr 02
Publications & Presentations
PubMed
- 7 citationsCrizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function.Nele Van Der Steen, Kaylee Keller, Henk Dekker, Letizia Porcelli, Richard Honeywell
Journal of Cellular Physiology. 2020-11-01 - 166 citationsLiquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung CancerChristian Rolfo, Philip C. Mack, Giorgio V. Scagliotti, Charu Aggarwal, Maria E. Arcila
Journal of Thoracic Oncology. 2021-10-01 - 22 citationsImmunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?Christian Rolfo, Giovanni Sortino, Evelien Smits, Francesco Passiglia, Giuseppe Bronte
Expert Review of Anticancer Therapy. 2014-09-23
Authored Content
- Liquid Biopsy handbook1/1/2017
Press Mentions
- Osimertinib plus Chemo Ups PFS, Toxicity in First LineSeptember 14th, 2023
- Biomarker in Liquid Biopsy for Lung Cancer Can Be More Reliable Than Tumour Biopsy, Study RevealsJune 3rd, 2022
- First Seven Days Spanish Language Podcast Gives Newly-Diagnosed Lung Cancer Patients Potentially Life-Saving Guidance from Lung Cancer Foundation of AmericaSeptember 7th, 2021
- Join now to see all
Committees
- Vice-president, International Society of Liquid Biopsy 2019 - Present
- Member, Membership committe ESMO 2018 - Present
- Member, IALSC Education Committee 2017 - Present
- Educational Chair, Oncology Latin American Society
Professional Memberships
- ASCOMember
- IASLCMember
- International Society of Liquid BiopsyMember
- Member
Other Languages
- Italian, Dutch, Portuguese, Spanish
External Links
- Univerity of Maryland Greenebaum Cancer Centerhttps://www.umms.org/find-a-doctor/profiles/dr-christian-rolfo-md-1134616873
- University of Antwerp, Belgiumhttps://www.uantwerpen.be/en/staff/christian-rolfo/
- Resaerchgatehttps://www.researchgate.net/profile/Christian_Rolfo
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: